SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-038515
Filing Date
2024-02-16
Accepted
2024-02-16 16:29:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d711090d424b5.htm 424B5 440257
2 GRAPHIC g711090g01a00.jpg GRAPHIC 44647
3 GRAPHIC g711090g01a39.jpg GRAPHIC 51613
  Complete submission text file 0001193125-24-038515.txt   574519
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B5 | Act: 33 | File No.: 333-256378 | Film No.: 24648836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)